CClinicalTrials.gg
RecruitingNCT06050421RODBT-ANUpdated Sep 22, 2023

Radically Open Dialectical Behaviour Therapy in Patients With Anorexia Nervosa

An interventional study of Radically Open Dialectical Behaviour Therapy (RO-DBT) and Treatment As Usual in Anorexia Nervosa, Anorexia Nervosa in Remission and Anorexia Nervosa Restricting Type, sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Recruiting at 1 site in Spain. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-22.

Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Randomized controlled clinical trial to evaluate the efficacy of "Radically Open Dialectical Behaviour Therapy" in patients with eating disorders: a proof-of-concept study.

Read the detailed description

Background: Up to 20% of patients with anorexia nervosa (AN) die and 50% relapse after the first episode, being its treatment a great challenge for clinicians. Most therapies excessively focus excessively on nourishment, which translates to temporarily restored weight with no improvements in psychosocial life. Radically Open Dialectical Behaviour Therapy (RO-DBT) is a transdiagnostic treatment designed to treat overcontrol, a key aspect in the functioning of patients with AN. To date no clinical trial (CT) has proved its efficacy on these patients or has demonstrated its biological underpinning mechanisms.

Methods: A randomized CT in AN patients will be conducted, where one group will receive treatment as usual (TAU) and the other one TAU with plus RO-DBT, being psychosocial adjustment the main outcome; other secondary variables will be ED symptoms, overcontrol characteristics, autistic traits and neuroimaging changes.

Discussion: The results will fill the a knowledge gap in AN treatment, expecting that patients who receive TAU with RO-DBT will have better social adjustment and less relapses at one year follow up. This is the first study examining neuroimaging changes in RO-DBT to better understand its underlying mechanisms

02

Conditions studied

  • Anorexia Nervosa
  • Anorexia Nervosa in Remission
  • Anorexia Nervosa Restricting Type

Keywords

  • anorexia nervosa, RODBT
03

In context

Anorexia

411 studies on the registry are indexed under Anorexia; 67 are open to participants now.

This study's planned enrollment of 96 is above the median of 41 across 287 interventional studies indexed under Anorexia.

Browse Anorexia studies →

Lead sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is the lead sponsor of 335 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • female patients
  • aged between 18 to 65 years old,
  • having a diagnosis of AN (DSM 5 criteria),
  • having had weigh restoration treatment (normal BMI considered >19 kg/m2)
  • having an overcontrol personality style assessed with the styles of coping Word-Pair Checklist scale (ASC-WP)

Exclusion criteria

Exclusion Criteria:

  • diagnosis of severe mental illness (schizophrenia or other psychosis, bipolar disorder, major depressive disorder, substance use disorder)
  • diagnosis of borderline personality disorder (BPD) or positive result in McLean Screening Instrument for BPD
  • mental retardation
  • being under standardized psychotherapy at the baseline
  • being illiterate or not able to understand Spanish language,
  • being left-handed
  • being pregnant for MRI requirements.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Investigator)
Enrollment
96 participants (estimated)

Study arms

  • Other
    Treatment as Usual (TAU)

    The TAU condition will follow the standard treatment of the EDs Unit of the HSCSP for AN. This treatment consists of visits with a psychiatrist with a frequency decided according to the clinical situation and, in some cases, nursing follow-up and/or relapse prevention group that takes place twice per month

    Other: Treatment As Usual

  • Experimental
    TAU + Radically Open Dialectical Behaviour Therapy (RO-DBT)

    2. TAU + skills of the RO-DBT: In this treatment branch, a RO-DBT skills training therapy will be added to TAU. Treatment and therapists: RO DBT skills training consists of a 30-week intervention program in which a set of skills specifically designed to treat overcontrol are taught on an ongoing basis. The duration of each session is 2 hours. Table X provides an overall summary of each skill training session content. Detailed and extensive information about the treatment can be found elsewhere \[24\], \[34\]. Three clinical psychologists and one psychiatrist will conduct the treatment, all of whom have undergone extensive training in RO DBT. A maximum of two therapists will be in charge of each session, and the same two therapists will go throughout each group intervention. The team will be supervised by an approved RO DBT supervisor to improve therapeutic skills and ensure adherence to the protocol.

    Behavioral: Radically Open Dialectical Behaviour Therapy (RO-DBT)

  • Other
    Healty controls

    All controls will complete data collection notebook and will undergo the same neuroimaging acquisition. There will not be follow-up for this group.

    Other: No intervention

Interventions

  • BehavioralRadically Open Dialectical Behaviour Therapy (RO-DBT)

    RO-DBT is a transdiagnostic intervention specifically designed to treat a spectrum of disorders characterized by excessive overcontrol such as resistant depression, avoidant and obsessive-compulsive personality disorders, mood disorders, anorexia nervosa and autism spectrum disorder.

    Also known as: non

  • OtherTreatment As Usual

    he TAU condition will follow the standard treatment of the EDs Unit of the HSCSP for AN. This treatment consists of visits with a psychiatrist with a frequency decided according to the clinical situation and, in some cases, nursing follow-up and/or relapse prevention group that takes place twice per month

  • OtherNo intervention

    All controls will complete data collection notebook and will undergo the same neuroimaging acquisition. There will not be follow-up for this group.

06

What researchers measure

Primary outcomes

  1. Quality of Life Enjoyment and Satisfaction Questionnaire, Q-LES-Q

    A self report questionarie that assesses quality of life. The range of scores is 0-100. Higher scores mean higher quality of life.

    Time frame: 6 months

  2. Quality of Life Enjoyment and Satisfaction Questionnaire, Q-LES-Q

    A self report questionarie that assesses quality of life. The range of scores is 0-100. Higher scores mean higher quality of life.

    Time frame: 12 months

Secondary outcomes

  1. Clinical relapses

    having BMI below 19kg/m2 during two or more weeks, and having a punctuation of the EAT above 21.

    Time frame: 6 months, 12 months

  2. Eating Disorder Inventory, EDI

    A self report questionarie that assesses eating disorder symptomatology. The range of scores is 0-192. Higher scores mean higher eating disorders sympthoms

    Time frame: 6 months, 12 monghs

  3. Autism-Spectrum Quotient, AQ

    A self report questionarie that assesses autistic traits. The range of scores is 0 to 50. Higher scores mean higher autistic traits.

    Time frame: 6 months, 12 months

  4. Rosenberg Self-Esteem Scale, RSE.

    A self report questionarie that assesses self steem. The scale ranges from 0-30. Higher scores mean higher self-esteem. The range scores is 0-60.

    Time frame: 6 months, 12 months

  5. Inventory of Interpersonal Problems (IIP-64)

    A screening measure for avoidant personality disorder (AVPD), and for personality disorder (PD) in general.

    Time frame: 6 months, 12 months

  6. Social Connectedness Scale-Revised, SCS-R

    This scale assesses the degree to which a person feel connected to others in their social environment. Scores range from 20 to 120 higher score indicates more connectedness to others.

    Time frame: 6 months, 12 months

  7. Depression Anxiety and Stress Scale 21 (DASS-21)

    A self-report scale designed to measure the negative emotional states of depression, anxiety and stress.

    Time frame: 6 months, 12 months

  8. Neuroimaging variables

    structural and functional magnetic resonance images will be acquired at baseline and at 1- month follow-up for all the participants, and in one single occasion for the healthy control group.

    Time frame: 6 months, 12 months

  9. Clinical Outcomes in Routine Evaluation-Outcome Measure, CORE-OM,

    A self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response. The broad spectrum nature of the measure means it captures a wide variety of problems associated with mental health difficulties, beyond typical symptom measures.

    Time frame: 6 months, 12 months

  10. Assessed with the Questionnaire envy in adults, CEA

    This is composed of 24 items representing all theoretical dimensions. Higher scores show higher envy.

    Time frame: 6 months, 12 months

07

Study locations

1 of 1 sites recruiting
  • Hospital de la Santa Creu i Sant Pau
    Barcelona, 08041, Spain
    Recruiting
08

References and documents

Publications

  • Lynch TR, Gray KL, Hempel RJ, Titley M, Chen EY, O'Mahen HA. Radically open-dialectical behavior therapy for adult anorexia nervosa: feasibility and outcomes from an inpatient program. BMC Psychiatry. 2013 Nov 7;13:293. doi: 10.1186/1471-244X-13-293. PubMed 24199611 ↗
  • Chen EY, Segal K, Weissman J, Zeffiro TA, Gallop R, Linehan MM, Bohus M, Lynch TR. Adapting dialectical behavior therapy for outpatient adult anorexia nervosa--a pilot study. Int J Eat Disord. 2015 Jan;48(1):123-32. doi: 10.1002/eat.22360. Epub 2014 Oct 27. PubMed 25346237 ↗
  • Isaksson M, Ghaderi A, Ramklint M, Wolf-Arehult M. Radically open dialectical behavior therapy for anorexia nervosa: A multiple baseline single-case experimental design study across 13 cases. J Behav Ther Exp Psychiatry. 2021 Jun;71:101637. doi: 10.1016/j.jbtep.2021.101637. Epub 2021 Jan 12. PubMed 33524917 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06050421
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborators
Fundació La Marató de TV3
Responsible party
Sponsor
First posted
Sep 22, 2023
Start date
Jun 22, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Sep 22, 2023

Study contacts

Cristina Carmona, Doctor
Contact
ccarmonaf@santpau.cat
0034650003427
Aina Avila
Contact
aavila@santpau.cat
Cristina Carmona
principal investigator · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion